Pierfrancesco Tassone Selected Research

Pierfrancesco Tassone Research Topics

Disease

104	Neoplasms (Cancer) 03/2024 - 04/2002
79	Multiple Myeloma 05/2024 - 10/2002
13	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2023 - 05/2010
9	Breast Neoplasms (Breast Cancer) 03/2024 - 05/2005
9	Hematologic Neoplasms (Hematological Malignancy) 03/2020 - 12/2004
9	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 11/2011
7	Ovarian Neoplasms (Ovarian Cancer) 12/2023 - 10/2009
6	Neoplasm Metastasis (Metastasis) 01/2023 - 12/2011
6	Colonic Neoplasms (Colon Cancer) 06/2012 - 04/2003
5	Melanoma (Melanoma, Malignant) 01/2022 - 01/2020
4	Inflammation (Inflammations) 03/2024 - 06/2005
4	Ovarian Epithelial Carcinoma 12/2023 - 05/2016
4	Genomic Instability 01/2021 - 01/2019
4	Carcinoma (Carcinomatosis) 02/2020 - 07/2002
4	Bone Diseases (Bone Disease) 11/2017 - 07/2009
3	Waldenstrom Macroglobulinemia (Macroglobulinemia) 09/2022 - 07/2004
3	Disease Progression 11/2017 - 08/2014
3	Pancreatic Neoplasms (Pancreatic Cancer) 03/2016 - 10/2009
3	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 07/2009 - 07/2005
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2023 - 01/2021
2	Adenocarcinoma of Lung 01/2023 - 01/2018
2	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 06/2022 - 01/2021
2	Hypoxia (Hypoxemia) 12/2021 - 05/2014
2	Paraproteinemias (Monoclonal Gammopathy) 01/2021 - 01/2020
2	Rare Diseases (Rare Disease) 01/2021 - 03/2020
2	Lung Neoplasms (Lung Cancer) 11/2020 - 01/2019
2	Lymphoma (Lymphomas) 10/2020 - 07/2006
2	Pneumonia (Pneumonitis) 01/2020 - 05/2010
2	Prostatic Neoplasms (Prostate Cancer) 11/2016 - 12/2011
2	Fever (Fevers) 04/2016 - 09/2015
2	Arthralgia (Joint Pain) 04/2016 - 09/2015
2	Rhinitis 04/2016 - 09/2015
2	Stomach Neoplasms (Stomach Cancer) 03/2016 - 01/2015

Drug/Important Bio-Agent (IBA)

37	MicroRNAs (MicroRNA)IBA 08/2023 - 09/2012
16	Biomarkers (Surrogate Marker)IBA 03/2024 - 10/2007
12	Monoclonal AntibodiesIBA 03/2021 - 07/2006
11	Immune Checkpoint InhibitorsIBA 01/2022 - 11/2016
9	Long Noncoding RNAIBA 01/2023 - 01/2018
8	AntigensIBA 06/2022 - 04/2002
8	Bortezomib (Velcade)FDA Link 02/2019 - 07/2005
8	Gemcitabine FDA Link 04/2016 - 07/2008
7	LNA-i-miR-221IBA 05/2024 - 01/2014
7	PlatinumIBA 12/2023 - 04/2009
7	Proteins (Proteins, Gene)FDA Link 12/2021 - 04/2003
6	locked nucleic acidIBA 01/2023 - 01/2014
6	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 10/2012
6	Dexamethasone (Maxidex)FDA LinkGeneric 10/2018 - 10/2002
6	Interleukin-6 (Interleukin 6)IBA 04/2013 - 10/2002
5	Poly(ADP-ribose) Polymerase InhibitorsIBA 12/2023 - 12/2011
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2021 - 08/2008
5	EpitopesIBA 01/2020 - 05/2011
5	mouse MIRN29 microRNAIBA 12/2017 - 10/2012
5	Bevacizumab (Avastin)FDA Link 09/2017 - 05/2010
4	CytokinesIBA 03/2024 - 09/2007
4	Carboplatin (JM8)FDA LinkGeneric 12/2023 - 12/2016
4	NivolumabIBA 01/2022 - 07/2019
4	Messenger RNA (mRNA)IBA 01/2021 - 01/2005
4	Untranslated RNA (Noncoding RNA)IBA 01/2020 - 06/2013
4	Peptides (Polypeptides)IBA 01/2020 - 09/2015
4	EnzymesIBA 01/2020 - 09/2015
4	Cisplatin (Platino)FDA LinkGeneric 09/2017 - 04/2009
4	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 09/2015 - 07/2008
4	Irinotecan (Camptosar)FDA LinkGeneric 06/2012 - 12/2004
4	Zoledronic Acid (Zometa)FDA Link 12/2011 - 10/2002
4	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 10/2007 - 10/2002
3	Melphalan (Alkeran)FDA LinkGeneric 05/2024 - 08/2008
3	pembrolizumabIBA 01/2023 - 01/2020
3	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2014
3	AntibodiesIBA 03/2021 - 04/2016
3	Thymidylate SynthaseIBA 04/2018 - 09/2015
3	tetraphenylporphine sulfonate (TPPS)IBA 04/2018 - 09/2015
3	Etoposide (VP 16)FDA LinkGeneric 09/2017 - 05/2010
3	Interleukin-2 (IL2)IBA 04/2016 - 01/2014
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 04/2016 - 05/2010
3	LipidsIBA 06/2014 - 01/2014
3	Fluorouracil (Carac)FDA LinkGeneric 01/2014 - 05/2010
3	ParaproteinsIBA 08/2005 - 07/2004
2	Trastuzumab (Herceptin)FDA Link 03/2024 - 03/2016
2	Cyclophilins (Cyclophilin)IBA 01/2024 - 06/2015
2	DNA Ligase ATPIBA 10/2022 - 01/2019
2	FlavonoidsIBA 10/2022 - 01/2020
2	Glycoproteins (Glycoprotein)IBA 06/2022 - 05/2011
2	IntegrinsIBA 01/2022 - 06/2011
2	Lenalidomide (CC 5013)FDA Link 08/2021 - 12/2009
2	PolyphenolsIBA 01/2020 - 07/2019
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 08/2019 - 12/2004
2	Proteasome Endopeptidase Complex (Proteasome)IBA 02/2019 - 01/2018
2	Glucuronosyltransferase (UDP Glucuronosyltransferase)IBA 01/2019 - 11/2011
2	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2018 - 07/2005
2	VaccinesIBA 04/2018 - 09/2015
2	Tumor Biomarkers (Tumor Markers)IBA 11/2017 - 01/2014
2	Endothelial Growth FactorsIBA 09/2017 - 05/2010
2	Histones (Histone)IBA 01/2017 - 05/2015
2	Protein Subunit VaccinesIBA 04/2016 - 09/2015
2	Histone Deacetylases (Histone Deacetylase)IBA 01/2016 - 11/2006

Therapy/Procedure

30	Therapeutics 01/2023 - 12/2004
16	Drug Therapy (Chemotherapy) 01/2022 - 05/2010
10	Immunotherapy 01/2023 - 04/2016
6	Radiotherapy 03/2023 - 07/2006
4	Aftercare (After-Treatment) 01/2022 - 12/2004